NYU Inflammatory Bowel Disease Center

New York, New York 10016

1 studies enrolling now · 1 studies all time

What they study most

Moderately to Severely Active Ulcerative Colitis

Studies at this site

• A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis — Recruiting now